脑转移瘤:临床影像的作用
本文综述脑转移瘤(BMs)影像学的临床挑战与作用,涉及不同原发肿瘤BMs发病率升高及筛查依据、筛选合适筛查患者的难点;检测以三维T1W MRI序列为金标准,辅以解剖、功能和代谢信息鉴别其他颅内病因;并讨论手术、立体定向放射外科治疗计划及治疗后监测中影像的作用,以及未来方向。
要点
- 三维T1W MRI序列是检测脑转移瘤的金标准。
- 附加磁敏感加权成像、扩散加权成像、灌注MRI、MR波谱和PET有助于鉴别脑转移瘤与其他颅内病因。
- 立体定向放射外科治疗计划需MRI与CT联合定位;局部和全身治疗后用常规MRI监测,先进影像用于区分真性进展与假性进展。
核心结论
- 脑转移瘤影像学近十年进展显著,三维T1W MRI为检测金标准,附加解剖、功能和代谢信息有助于鉴别诊断,影像在筛查、治疗计划及治疗后监测中均发挥作用,未来方向包括放射组学、新生物标志物、新型内源性对比剂和诊疗一体化。
研究设计与样本
- 综述,讨论脑转移瘤在临床实践中的主要挑战并描述影像的作用,检索范围与纳入文献未报告。
关键影像表现/征象
- 三维T1W MRI序列是检测脑转移瘤的金标准。
- 磁敏感加权成像、扩散加权成像等解剖信息,灌注MRI等功能信息及MR波谱、PET等代谢信息有助于将脑转移瘤与其他颅内病因鉴别。
- 手术切除前影像用于筛选手术患者,术中可借助神经导航、荧光引导手术和超声辅助。
- 立体定向放射外科治疗计划需将MRI与CT联合。
- 局部和全身治疗后采用常规MRI监测,先进影像越来越多用于区分真性肿瘤进展与假性进展。
诊断标准与关键数值
- 三维T1W MRI序列为检测脑转移瘤的金标准。
临床应用与阅片要点
- 不同原发肿瘤的脑转移瘤发病率升高,但并非所有癌症患者在病程中都会发生脑转移瘤,筛选合适的筛查患者是一大挑战。
- 检测脑转移瘤以三维T1W MRI序列为金标准,必要时附加磁敏感加权成像、扩散加权成像、灌注MRI、MR波谱和PET以鉴别其他颅内病因。
- 立体定向放射外科治疗计划需MRI与CT联合;术后及局部、全身治疗后用常规MRI监测,先进影像用于区分真性进展与假性进展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Imaging of brain metastases (BMs) has advanced greatly over the past decade. In this review, we discuss the main challenges that BMs pose in clinical practice and describe the role of imaging.Firstly, we describe the increased incidence of BMs of different primary tumours and the rationale for screening. A challenge lies in selecting the right patients for screening: not all cancer patients develop BMs in their disease course.Secondly, we discuss the imaging techniques to detect BMs. A three-dimensional (3D) T1W MRI sequence is the golden standard for BM detection, but additional anatomical (susceptibility weighted imaging, diffusion weighted imaging), functional (perfusion MRI) and metabolic (MR spectroscopy, positron emission tomography) information can help to differentiate BMs from other intracranial aetiologies.Thirdly, we describe the role of imaging before, during and after treatment of BMs. For surgical resection, imaging is used to select surgical patients, but also to assist intraoperatively (neuronavigation, fluorescence-guided surgery, ultrasound). For treatment planning of stereotactic radiosurgery, MRI is combined with CT. For surveillance after both local and systemic therapies, conventional MRI is used. However, advanced imaging is increasingly performed to distinguish true tumour progression from pseudoprogression.FInally, future perspectives are discussed, including radiomics, new biomarkers, new endogenous contrast agents and theranostics.
引用
- Derks, van der Veldt, Smits, et al. Brain metastases: the role of clinical imaging. Br J Radiol. 2021. PMID: 34808072. doi:10.1259/bjr.20210944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。